Mari Thomas, MD, PhD

Consultant Haematologist
University College Hospitals London NHS Foundation Trust

Consultant Haematologist
Thrombosis Team
Lead, Cancer VTE Service
University College London
London, England, UK

Presentation(s):

• OC 04.4 - Disease Relapse in immune Thrombotic Thrombocytopenic Purpura and treatment with Anti-CD20 Monoclonal Antibodies – 10-years’ experience from the UK TTP Registry

  Saturday, July 9, 2022
  1:45 PM – 2:00 PM

• OC 04.5 - Immune Medicated Thrombotic Thrombocytopenic Purpura relapse is associated with HLA-DRB1*15:01

  Saturday, July 9, 2022
  2:00 PM – 2:15 PM

• PB0297 - The use of Obinutuzumab and Ofatumumab in the treatment of immune Thrombotic Thrombocytopenic Purpura

  Sunday, July 10, 2022
  6:30 PM – 7:30 PM

• PB0307 - Results of a Single-centre Targeted Screening Approach to Identify Potential Occult Cases of Pregnancy-associated Thrombotic Thrombocytopenic Purpura (TTP).

  Sunday, July 10, 2022
  6:30 PM – 7:30 PM

• PB0310 - Longitudinal kinetics of B-cell subsets in Immune Thrombotic Thrombocytopenic Purpura Patients: Relapses vs Remission

  Sunday, July 10, 2022
  6:30 PM – 7:30 PM

• SS 14.2 - Cancer Associated Thrombosis (CAT): Burden of Disease and Current Treatment Options

  Monday, July 11, 2022
  7:05 AM – 7:15 AM

• OC 51.2 - Changes in VWF, ADAMTS13, and Complement in Preeclampsia, HELLP syndrome and Other Obstetric Complications: a Single Centre Observational Study.

  Tuesday, July 12, 2022
  11:00 AM – 11:15 AM

• PB1366 - Safety and Efficacy of Apixaban as Thromboprophylaxis in Multiple Myeloma Patients Receiving Chemotherapy: a Prospective Cohort Study

  Tuesday, July 12, 2022
  6:30 PM – 7:30 PM